Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol for complications of autologous hematopoietic stem cell transplantation
IRCT2016052727435N2Phase 3Completed
- Sponsor
- Hematology, Oncology and Stem Cell Transplantation Research Center
- Start
- Apr 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of calcitriol in Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL) and multiple myeloma (MM), sponsored by Hematology, Oncology and Stem Cell Transplantation Research Center. Started Apr 2016; status: completed.
02
Drugs
calcitriol
03
Conditions
Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)multiple myeloma (MM)
Beyond the preview
Go deeper on IRCT2016052727435N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016052727435N2.